MedTrace Logo

Novel Glaucoma Diagnostics

NCT00286637 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 5000

Last updated 2024-08-15

No results posted yet for this study

Summary

The purpose of this research is to evaluate novel technologies for the assessment of ocular structure and function, including the scanning device called Optical Coherence Tomography (OCT). We will test the OCT and other devices in their ability to image diseases of the eye and also compare the measurements made with OCT to those of other imaging and visual field devices approved by the Food and Drug Administration (FDA). OCT may be useful for the early diagnosis and monitoring of a variety of types of eye diseases

Conditions

Sponsors & Collaborators

  • National Eye Institute (NEI)

    collaborator NIH

  • Wills Eye

    lead OTHER

Principal Investigators

  • Joel S Schumann, MD · Wills Eye Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2000-08-01
Primary Completion
2029-07-31
Completion
2029-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00286637 on ClinicalTrials.gov